1 |
Spalletta G, Guida G, De Angelis D, Caltagirone C. Predictors of cognitive level and depression severity are different in patients with left and right hemispheric stroke within the first year of illness. J Neurol 2002;249(11):1541-51.
DOI
ScienceOn
|
2 |
Kauhanen ML, Korpelainen J, Hiltunen P, Maatta R, Mononen H, Brusin E, et al. Aphasia, depression, and non-verbal cognitive impairment in ischaemic stroke. Cerebrovasc Dis 2000;10(6):455-61.
DOI
ScienceOn
|
3 |
Robinson RG. Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003;54(3):376-87.
DOI
ScienceOn
|
4 |
House A, Dennis M, Warlow C, Hawton K, Molyneux A. The relationship between intellectual impairment and mood disorder in the first year after stroke. Psychol Med 1990;20(4):805-14.
DOI
|
5 |
Wiart L, Petit H, Joseph P, Mazaux J, Barat M. Fluoxetine in Early Poststroke Depression A Double-Blind Placebo-Controlled Study. Stroke 2000;31(8):1829-32.
DOI
ScienceOn
|
6 |
Paolucci S, Antonucci G, Grasso MG, Morelli D, Troisi E, Coiro P, et al. Post-stroke depression, antidepressant treatment and rehabilitation results. Cerebrovasc Dis 2001;12(3):264-71.
DOI
ScienceOn
|
7 |
Lipsey J, Pearlson G, Robinson R, Rao K, Price T. Nortriptyline treatment of post-stroke depression: a double-blind study. The Lancet 1984;323(8372):297-300.
DOI
ScienceOn
|
8 |
Andersen G, Vestergaard K, Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994;25(6):1099-104.
DOI
ScienceOn
|
9 |
Chemerinski E, Robinson RG, Kosier JT. Improved recovery in activities of daily living associated with remission of poststroke depression. Stroke 2001;32(1):113-7.
DOI
ScienceOn
|
10 |
Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 2011;10(2):123-30.
DOI
ScienceOn
|
11 |
Jorge RE, Robinson RG, Arndt S, Starkstein S. Mortality and poststroke depression: a placebocontrolled trial of antidepressants. Am J Psychiatry 2003;160(10):1823-9.
DOI
ScienceOn
|
12 |
Yi Z, Liu F, Zhai S. Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta‐analysis. Int J Clin Pract 2010;64(9):1310-7.
DOI
ScienceOn
|
13 |
Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008;299(20):2391-400.
DOI
ScienceOn
|
14 |
Chen W, Liu F, Yang A. Study of effect of integrative Chinese herbs with fluoxetine on rehabilitation of neurological impairment in patients with post-stroke depression. Journal of Chengdu University of Traditional Chinese Medicine 2001;24(4):20.
|
15 |
Stamenkovic M, Schindler S, Kasper S. Therapy of post-stroke depression with fluoxetine. A pilot project. Nervenarzt 1996;67(1):62-7.
|
16 |
Mead GE, Hsieh CF, Lee R, Kutlubaev M, Claxton A, Hankey GJ, et al. Selective Serotonin Reuptake Inhibitors for Stroke Recovery A Systematic Review and Meta-analysis. Stroke 2013;44(3):844-50.
DOI
ScienceOn
|
17 |
Li LT, Wang SH, Ge HY, Chen J, Yue SW, Yu M. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) and fluoxetine on post-stroke depression. J Altern Complement Med 2008;14(7):841-6.
DOI
ScienceOn
|
18 |
Gonzalez-Torrecillas JL, Mendlewicz J, Lobo A. Effects of early treatment of poststroke depression on neuropsychological rehabilitation. Int Psychogeriatr 1995;7(04):547-60.
DOI
ScienceOn
|
19 |
Paolucci S. Epidemiology and treatment of post-stroke depression. Neuropsychiatr Dis Treat 2008;4(1):145.
|
20 |
Murray V, Arbin Mv, Bartfai A, Berggren AL, Landtblom AM, Lundmark J, et al. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry 2005;66(6):708-16.
DOI
|
21 |
Robinson RG, Schultz SK, Castillo C, Kopel T, Kosier JT, Newman RM, et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry 2000;157(3):351-9.
DOI
ScienceOn
|
22 |
이상택, 김근우, 구병수. 삼정환 (三精丸) 의 항우울 효과에 대한 실험적 연구. 동의신경정신과학회지 2008;19(3):101-15.
|
23 |
선종주, 정세연, 황재웅, 김석민, 정재한, 최창민, 등. 중풍후우울증 환자에 대한 향기침요법의 임상적 연구. 대한한방내과학회지 2006;27(2):480-7.
|
24 |
강형원, 장현호, 강인선, 문형철, 황유진, 유영수. 우울증(憂鬱症) 의 한방적(韓方的) 이해(理解)에 관한 문헌고찰(文獻考察). 동의신경정신과학회지 2001;12(2):1-15.
|
25 |
이일석, 박기언, 홍해진, 송인자, 성강경, 이상관. 뇌졸중 후 우울증과 한열허실 변증의 상관관계. 대한한방내과학회지 2014;35(1):50-8.
|
26 |
최지혜, 김래희, 윤종민, 문병순. 뇌졸중후 우울증 침치료의 임상연구에 대한 고찰. 동의생리병리학회지 2011;25(6):1119-28.
|
27 |
제준태, 이상관. 뇌졸중 후 우울증에 대한 황련 해독탕 약침의 안전성 및 유효성 평가를 위한 임상 시험. 대한약침학회지 2010;13(2):67-73.
|
28 |
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4(6):561.
DOI
ScienceOn
|
29 |
나병조, 정재한, 최창민, 홍진우, 김태훈, 이준우, 등. 중풍후우울증에 대한 반하후박탕의 유효성 및 적응증 평가. 대한한방내과학회지 2005;26(3):563-74.
|
30 |
Youn JI, Sung KK, Song BK, Kim M, Lee S. Effects of Electro-Acupuncture Therapy on Post-Stroke Depression in Patients with Different Degrees of Motor Function Impairments: a Pilot Study. J Phys Ther Sci 2013;25(6):725.
DOI
ScienceOn
|
31 |
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23(1):56.
DOI
|
32 |
Choi-Kwon S, Han SW, Kwon SU, Kang DW, Choi JM, Kim JS. Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness a double-blind, placebocontrolled study. Stroke 2006;37(1):156-61.
DOI
ScienceOn
|
33 |
Weng S, Tang J, Wang G, Wang X, Wang H. Comparison of the Addition of Siberian Ginseng (Acanthopanax senticosus) Versus Fluoxetine to Lithium for the Treatment of Bipolar Disorder in Adolescents: A Randomized, Double-Blind Trial. Current Therapeutic Research 2007;68(4):280-90.
DOI
ScienceOn
|
34 |
허준. (對譯)東醫寶鑑. 서울: 법인문화사; 1999, p. 205.
|
35 |
식품의약품안전처. 천심액(천왕보심단) [cited 1998 Oct 21]. Available from: http://ezdrug.mfds.go.kr/kfda2.
|
36 |
식품의약품안전처. 푸로작캡슐20밀리그램(플루옥세틴염산염) [cited 2005 Dec 17]. Available from: http://drug.mfds.go.kr/html/bxsSearchDrugProduct.jsp?item_Seq=200409973.
|
37 |
危亦林. 世醫得效方. 서울: 醫聖堂; 1990, p. 217.
|
38 |
呂光榮. 中醫腦病證治. 북경: 과학기술문헌출판사; 1991, p. 72-81.
|
39 |
박종흠, 배창욱, 전현숙, 홍성유, 박선동. 천왕보심단(天王補心丹)의 항우울효과 및 monoamine 대사에 미치는 영향. 대한한의학방제학회지 2004;12(2):77-93.
|
40 |
Chen Q. The Clinical and pharmacology of the Chinese patent medicine. Beijing: Ren Min Wei Min Chu Ban She; 1998, p. 342-59.
|
41 |
김남재, 공영윤, 장순욱. 생약복합제제(生藥複合製劑)의 약효연구(藥效硏究)(제37보)(第37報)-천왕보심단(天王補心丹)이 중추신경계(中樞神經系) 및 순환기계(循環器系) 에 미치는 영향(影響). 생약학회지 1988;19(3):208-15.
|
42 |
Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U. Early fluoxetine treatment of post-stroke depression. J Neurol 2003;250(3):347-51.
DOI
ScienceOn
|
43 |
Huffman J, Stern TA. Acute psychiatric manifestations of stroke: a clinical case conference. Psychosomatics 2003;44(1):65-75.
DOI
ScienceOn
|
44 |
Robinson RG, Spalletta G. Poststroke depression: a review. Can J Psychiatry 2010;55(6):341.
DOI
|